India  
NewsR.in
> >

Drug companies avert landmark opioids trial as talks on $48 billion settlement set to resume

Reuters India Monday, 21 October 2019
Four large drug companies could resume talks on Tuesday to try to reach a $48 billion settlement of all opioid litigation against them, after agreeing with two Ohio counties to a $260 million deal to avert the first federal trial over their role in the U.S. opioid epidemic.
0
shares
ShareTweetSavePostSend
 

You Might Like


Recent related videos from verified sources

Charles Schwab to Reportedly Purchase TD Ameritrade [Video]Charles Schwab to Reportedly Purchase TD Ameritrade

Charles Schwab to Reportedly Purchase TD Ameritrade . On Nov. 21, numerous sites reported that Charles Schwab is in talks to buy TD Ameritrade. The deal would reportedly be worth $26 billion...

Credit: Wibbitz Top Stories     Duration: 01:11Published

Opioid Use May Negatively Impact Sleep [Video]Opioid Use May Negatively Impact Sleep

Long-term use of prescription opioids may cause those who rely on them for pain relief to lose sleep . The American Academy of Sleep Medicine (AASM) warns that the drug may reduce sleep quality. The..

Credit: Wochit News     Duration: 00:33Published


Tweets about this

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2019 newsR Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest